Market News (Page 9) - TendieTensor

Market News Page 9 of 281 • 7,014 articles

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

GlobeNewswire Inc. • Na

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

01/09/2026 07:00 AM • Aquestive Therapeutics received an FDA letter identifying deficiencies in its Anaphylm (dibutepinephrine) sublingual film NDA that preclude labeling discussions, though the FDA confirmed its review remains ongoing with no final decision made. The company maintains confidence in Anaphylm's potential and is advancing global regulatory expansion in Canada, Europe, and the UK. Aquestive reported approximately $120 million in cash and cash equivalents as of December 31, 2025.

BMLpG - Sold 37 million shares, reducing position by 6%
AQST - The company received an FDA letter identifying unspecified deficiencies in its Anaphylm NDA that preclude labeling discussions, creating regulatory uncertainty and potential delays to the January 31, 2026 PDUSA action date. While management expresses confidence and the company has adequate cash reserves, the identification of deficiencies represents a setback in the approval process for their lead product candidate.

#FDA regulatory deficiencies #Anaphylm sublingual film #NDA approval #epinephrine therapy #global expansion #cash position #clinical development

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

GlobeNewswire Inc. • Na

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

01/09/2026 07:00 AM • MapLight Therapeutics announced that its Phase 2 ZEPHYR trial for ML-007C-MA (schizophrenia treatment) and Phase 2 IRIS trial for ML-004 (autism spectrum disorder) are progressing ahead of schedule, with topline results now expected in Q3 2026. The company cited accelerated enrollment pace and disciplined execution as drivers of the timeline acceleration.

BACpS - Sold 37 million shares, reducing position by 6%
MPLT - The company reported accelerated enrollment in its Phase 2 trials ahead of schedule, demonstrating strong execution and momentum in clinical development. The narrowed timing guidance to Q3 2026 for both ZEPHYR and IRIS trials indicates progress and operational efficiency, which are positive indicators for investors and stakeholders.

#Phase 2 clinical trials #ZEPHYR trial #IRIS trial #schizophrenia #autism spectrum disorder #topline results #enrollment acceleration #CNS disorders

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

GlobeNewswire Inc. • Amarin Corporation Plc

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

01/09/2026 07:00 AM • Amarin Corporation announced that its VASCEPA/VAZKEPA (icosapent ethyl) franchise is well-positioned to benefit from recent breakthroughs in elevated triglyceride therapies. The company highlighted that new ApoC-III-targeted injectables complement rather than compete with VASCEPA, which has been prescribed over 25 million times globally. Amarin expects payor-driven step-therapy programs to increase utilization of VASCEPA as a cost-effective first-line therapy before access to newer, more expensive alternatives. The company also secured an exclusive long-term license agreement with Recordati S.p.A. to commercialize VAZKEPA across 59 countries in Europe.

BACpQ - Sold 37 million shares, reducing position by 6%
RICFY - Recordati secured an exclusive long-term license and supply agreement to commercialize VAZKEPA across 59 countries in Europe, representing a significant commercial opportunity with patent protection extending until 2039.

#VASCEPA #VAZKEPA #icosapent ethyl #elevated triglycerides #cardiovascular disease #step-therapy programs #ApoC-III injectables #REDUCE-IT trial #Recordati agreement

Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems

GlobeNewswire Inc. • Aurora Mobile Limited

Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems

01/09/2026 07:00 AM • Aurora Mobile Limited has announced a strategic partnership with Xiaoe Inc. to integrate its JPush intelligent push notification solution into Xiaoe's private domain SaaS platform. The integration aims to improve message delivery rates and reliability across multiple operating systems and mobile brands, enabling merchants to deploy more refined operational strategies through advanced audience segmentation features.

BACpP - Sold 37 million shares, reducing position by 6%
JG - The company announced a strategic partnership that expands JPush's market reach and application, demonstrating business growth and strengthened market position in the customer engagement technology sector. The partnership validates Aurora Mobile's technology capabilities and opens new revenue opportunities.

#strategic partnership #push notification #JPush #private domain SaaS #message delivery #customer engagement #audience segmentation

Pulmonary Function Testing Market Size to Hit USD 5.66 Billion by 2033, Growing at a CAGR of 6.65% - SNS Insider

GlobeNewswire Inc. • Sns Insider

Pulmonary Function Testing Market Size to Hit USD 5.66 Billion by 2033, Growing at a CAGR of 6.65% - SNS Insider

01/09/2026 07:00 AM • The global pulmonary function testing market is projected to grow from USD 3.39 billion in 2025 to USD 5.66 billion by 2033, with a CAGR of 6.65%. Growth is driven by rising prevalence of chronic respiratory diseases, an aging population, and technological advancements in diagnostic devices. The U.S. market is expected to expand from USD 1.03 billion to USD 1.67 billion during the same period. Asia Pacific is anticipated to experience the fastest regional growth at 7.27% CAGR.

BACpO - Sold 37 million shares, reducing position by 6%
TFX - Listed as a major player in the market but no specific recent developments or company-specific information provided in the article.

#pulmonary function testing #respiratory diseases #COPD #asthma #spirometry #diagnostic devices #healthcare market #medical devices

iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger

Benzinga • Globe Newswire

iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger

01/09/2026 07:00 AM • iHerb has completed its acquisition of Vitacost from Kroger, significantly expanding iHerb's U.S. market presence. The deal combines iHerb's global supply chain with Vitacost's 40,000+ health and wellness products and loyal customer base, positioning the combined entity as a top online destination for health, nutrition and wellness products.

BACpN - Sold 37 million shares, reducing position by 6%
KR - Kroger is divesting Vitacost to iHerb. While this represents a strategic exit from the online health and wellness retail business, there is no indication of financial loss or gain, making this a neutral transaction for Kroger's portfolio optimization.

#acquisition #iHerb #Vitacost #Kroger #health and wellness #e-commerce #vitamins and supplements #U.S. market expansion

GlobeNewswire Inc. • Na

iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger

01/09/2026 07:00 AM • iHerb Holdings has completed its acquisition of Vitacost.com from The Kroger Co. The deal combines two major online health and wellness retailers, giving iHerb immediate access to Vitacost's loyal U.S. customer base and 40,000+ products while providing Vitacost customers access to iHerb's global supply chain and fulfillment platform. The transaction is expected to accelerate iHerb's U.S. market presence and strengthen category leadership in vitamins, minerals, supplements and natural products.

BACpM - Sold 37 million shares, reducing position by 6%
KR - Kroger is divesting Vitacost, which could indicate portfolio optimization or strategic refocusing. The transaction itself is presented as a completed sale without commentary on Kroger's strategic direction or financial impact.

#acquisition #iHerb #Vitacost #health and wellness #vitamins and supplements #e-commerce #U.S. market expansion #customer base #supply chain

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

GlobeNewswire Inc. • Na

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

01/09/2026 06:00 AM • RadNet, Inc. (NASDAQ: RDNT), a national diagnostic imaging services provider, announced that its executive leadership team will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The presentation will be led by President and CEO Dr. Howard Berger, along with CFO Mark Stolper, Chief Strategy Officer Dr. Gregory Sorensen, and RadNet Digital Health CEO Kees Wesdorp. RadNet operates 407 outpatient imaging centers across eight states and employs over 11,000 team members.

BAC - Sold 37 million shares, reducing position by 6%
RDNT - RadNet's participation in a major healthcare industry conference with senior executive representation demonstrates confidence in the company's strategic direction and growth trajectory. The company's substantial network of 407 imaging centers and 11,000+ employees indicates strong operational scale and market position.

#diagnostic imaging #J.P. Morgan Healthcare Conference #outpatient imaging centers #healthcare services #radiology technology

Pandora expects to deliver 6% organic growth and around 24% EBIT margin in 2025

GlobeNewswire Inc. • Na

Pandora expects to deliver 6% organic growth and around 24% EBIT margin in 2025

01/09/2026 05:46 AM • Pandora announced preliminary 2025 results with 6% organic growth, marginally below the 7-8% guidance, driven by weak consumer sentiment particularly in North America during Q4. The company maintained its ~24% EBIT margin guidance despite headwinds from commodity prices, FX rates, and tariffs. New CEO Berta de Pablos-Barbier, appointed January 1, 2026, will outline strategic priorities including plans to reduce commodity exposure and strengthen brand desirability.

BACpB - Sold 37 million shares, reducing position by 6%
PNDRY - While the company maintained EBIT margin guidance, organic growth of 6% fell short of the 7-8% guidance range. Q4 performance was particularly weak with flat like-for-like growth, North America showing only 2% LFL growth, and EMEA declining at -1%. The new CEO's focus on 'course-correcting in select areas' and reducing commodity exposure suggests operational challenges ahead, though the company maintains strong fundamentals with 78% gross margins.

#2025 results #organic growth #North America weakness #EBIT margin #new CEO #commodity exposure #consumer sentiment #jewelry brand

Stock Market Today: Nasdaq 100, S&P 500 Futures Gain As Investors Await December Jobs Report— General Motors, Offerpad, Tilray In Focus

Benzinga • Rishabh Mishra

Stock Market Today: Nasdaq 100, S&P 500 Futures Gain As Investors Await December Jobs Report— General Motors, Offerpad, Tilray In Focus

01/09/2026 05:43 AM • U.S. stock futures advanced on Friday as investors awaited the December jobs report and the Supreme Court's ruling on Trump's tariffs. Major indices showed modest gains with SPY and QQQ trading higher in premarket. Key movers included General Motors facing EV investment losses, Tilray surging on earnings beats, Offerpad jumping on Trump's housing proposal, and Rio Tinto declining amid merger talks with Glencore.

BACpE - Sold 37 million shares, reducing position by 6%
GM - Stock down 0.63% in premarket following a $7.1 billion loss from electric vehicle investments, indicating significant financial headwinds in the EV sector.

#stock market #futures #jobs report #tariffs #earnings #Federal Reserve #interest rates #Iran tensions #crude oil

$6.25+ Bn Handwriting Recognition Artificial Intelligence Global Markets, 2019-2024, 2024-2029F, 2034F: Opportunities in Document Processing, AI-powered Handwriting Analysis, and Mobile Integration

GlobeNewswire Inc. • Researchandmarkets.Com

$6.25+ Bn Handwriting Recognition Artificial Intelligence Global Markets, 2019-2024, 2024-2029F, 2034F: Opportunities in Document Processing, AI-powered Handwriting Analysis, and Mobile Integration

01/09/2026 05:37 AM • The global handwriting recognition AI market is experiencing rapid growth, expanding from $2.75 billion in 2024 to $3.25 billion in 2025, with projections to reach $6.27 billion by 2029 at a 17.8% CAGR. Growth is driven by increased digital documentation adoption, pen-based computing devices, mobile integration, and AI/machine learning advancement. North America leads the market while Asia-Pacific emerges as the fastest-growing region, though U.S. tariffs are impacting hardware manufacturing and supply chains.

BACpK - Sold 37 million shares, reducing position by 6%
MSFT - Listed as a major player continuing to innovate in the handwriting recognition AI market, which is experiencing strong growth with 17.8% CAGR through 2029.

#handwriting recognition #artificial intelligence #document processing #neural networks #mobile integration #cloud platforms #digital documentation #machine learning

Launch Azimuth Analysis Software Market Research Report 2026: Airbus, Lockheed Martin, and Northrop Grumman are Increasingly Focusing on Real-time Trajectory Simulations & Advanced Integration

GlobeNewswire Inc. • Researchandmarkets.Com

Launch Azimuth Analysis Software Market Research Report 2026: Airbus, Lockheed Martin, and Northrop Grumman are Increasingly Focusing on Real-time Trajectory Simulations & Advanced Integration

01/09/2026 05:34 AM • The launch azimuth analysis software market is experiencing rapid growth, expanding from $1.13 billion in 2024 to an anticipated $1.84 billion by 2029 (10.2% CAGR). Growth is driven by rising satellite mega-constellations, commercial space exploration, and AI-driven trajectory optimization. Key players like Airbus, Lockheed Martin, and Northrop Grumman are focusing on real-time trajectory simulations and advanced integrations. Industry consolidation is evident with Synopsys's $35 billion acquisition of Ansys to enhance AI capabilities.

BACpL - Sold 37 million shares, reducing position by 6%
EADSY - Explicitly mentioned as a key industry player increasingly focusing on real-time trajectory simulations and advanced software integrations, positioning the company well in a growing market.

#launch azimuth analysis software #trajectory simulation #satellite mega-constellations #space exploration #AI optimization #mission planning #aerospace and defense

$114.5 Bn Air Transport MRO Markets, 2020-2025, 2025-2030F, 2035F - Growth Opportunities in Predictive Maintenance, Blockchain for Secure Records, and Hybrid Models for Cost Efficiency

GlobeNewswire Inc. • Researchandmarkets.Com

$114.5 Bn Air Transport MRO Markets, 2020-2025, 2025-2030F, 2035F - Growth Opportunities in Predictive Maintenance, Blockchain for Secure Records, and Hybrid Models for Cost Efficiency

01/09/2026 04:56 AM • The global air transport MRO market is experiencing robust growth, expanding from $89.42 billion in 2025 to $93.6 billion in 2026, with projections to reach $114.15 billion by 2030 at a 5.1% CAGR. Growth is driven by increased air travel (36.9% rise in 2023), digital tool adoption, and advanced technologies including AI, IoT, robotics, and blockchain. Asia-Pacific leads the market, though trade tensions and tariffs present challenges.

AIR - Company acquired Trax for $120 million to merge aftermarket offerings with advanced fleet management software, demonstrating strategic investment in digital solutions and positioning for growth in the expanding MRO market.

#MRO market #predictive maintenance #blockchain #AI and IoT #air transport #fleet maintenance #digital transformation #Asia-Pacific

$17.74 Bn Defense Drone Markets, 2020-2025, 2025-2030F, 2035F - Surging Demand for Stealth Designs and Multi-mission Capabilities, with Asia-Pacific Leading Growth

GlobeNewswire Inc. • Researchandmarkets.Com

$17.74 Bn Defense Drone Markets, 2020-2025, 2025-2030F, 2035F - Surging Demand for Stealth Designs and Multi-mission Capabilities, with Asia-Pacific Leading Growth

01/09/2026 04:53 AM • The global defense drone market is expected to grow from $12.75 billion in 2025 to $17.74 billion by 2030 at a 6.6% CAGR. Growth drivers include increased military adoption of UAVs, advancements in AI and autonomous systems, rising global defense budgets ($2.71 trillion in 2024), and expansion of multi-mission capabilities. Asia-Pacific is anticipated to be the fastest-growing region, while North America led in 2025.

RTX - Listed as a leading player in the expanding defense drone market with strong growth projections and increasing military adoption of UAV technologies.

#defense drones #UAVs #autonomous systems #military technology #Asia-Pacific growth #defense budgets #stealth designs #sensor technology #AI integration

Induction Motors Market Size to Hit USD 39.15 Billion by 2033 | Research by SNS Insider

GlobeNewswire Inc. • Sns Insider

Induction Motors Market Size to Hit USD 39.15 Billion by 2033 | Research by SNS Insider

01/09/2026 04:50 AM • The global induction motor market is projected to grow from USD 23.38 billion in 2025 to USD 39.15 billion by 2033 at a CAGR of 6.69%, driven by industrial automation, energy-efficient manufacturing, and renewable energy investments. However, high energy-efficiency compliance costs and rising raw material prices pose challenges to market expansion. Asia Pacific leads with 42.67% market share, while renewable energy applications are expected to grow fastest at 9.21% CAGR.

RRX - Identified as a leading market player but no specific recent developments or product launches mentioned in the article.

#induction motors #industrial automation #energy efficiency #manufacturing #renewable energy #market growth #CAGR 6.69% #Asia Pacific #compliance costs

$1.88 Bn Digital Aerospace MRO Markets, 2020-2025, 2025-2030F, 2035F: Opportunities in Adoption of AI and IoT for Predictive Maintenance, Blockchain for Traceability, and Cloud-based Suites

GlobeNewswire Inc. • Researchandmarkets.Com

$1.88 Bn Digital Aerospace MRO Markets, 2020-2025, 2025-2030F, 2035F: Opportunities in Adoption of AI and IoT for Predictive Maintenance, Blockchain for Traceability, and Cloud-based Suites

01/09/2026 04:49 AM • The global digital aerospace MRO market is experiencing rapid expansion, projected to grow from $1.02 billion in 2025 to $1.88 billion by 2030 at a 12.8% CAGR. Key growth drivers include AI and IoT adoption for predictive maintenance, blockchain for traceability, and cloud-based platforms. North America leads the market, with major players innovating in digital solutions to minimize aircraft downtime amid rising global air traffic.

IBM - Listed as a key market player in the expanding digital aerospace MRO sector, benefiting from growing demand for AI and advanced digital solutions.

#digital aerospace MRO #predictive maintenance #AI and IoT #blockchain #cloud-based platforms #aircraft maintenance #market growth #North America

Space Traffic Management Markets, 2020-2025, 2025-2030F, 2035F - Increased Adoption of Advanced Lidar and Optical Sensors for Space Traffic Monitoring

GlobeNewswire Inc. • Researchandmarkets.Com

Space Traffic Management Markets, 2020-2025, 2025-2030F, 2035F - Increased Adoption of Advanced Lidar and Optical Sensors for Space Traffic Monitoring

01/09/2026 04:45 AM • The space traffic management market is experiencing rapid growth, rising from $17.66 billion in 2025 to $19.39 billion in 2026 with a projected CAGR of 10.1% through 2030. Growth is driven by increased satellite deployments, rising space debris threats, demand for collision-risk assessment services, and commercialization of management services for private operators. Advanced lidar and optical sensors, AI-driven collision avoidance tools, and regulatory framework development are key market drivers.

GOOGL - Buffett bought 17.8 million shares for a $4.3 billion investment, representing a significant new position
LHX - Identified as a key market player positioned to benefit from the 10.1% CAGR growth in space traffic management services and technologies.

#space traffic management #satellite monitoring #space debris #collision avoidance #lidar sensors #orbital congestion #space situational awareness #autonomous systems

$43+ Bn Airborne ISR Markets, 2020-2025, 2025-2030F, 2035F - Growing Counterterrorism Efforts and Geopolitical Tensions Further Drive Market Growth

GlobeNewswire Inc. • Researchandmarkets.Com

$43+ Bn Airborne ISR Markets, 2020-2025, 2025-2030F, 2035F - Growing Counterterrorism Efforts and Geopolitical Tensions Further Drive Market Growth

01/09/2026 04:45 AM • The global airborne ISR market is projected to grow from $31.59 billion in 2025 to $43.04 billion by 2030, with a CAGR of 6.2%. Growth is driven by increasing demand for real-time military intelligence, rising counterterrorism efforts, geopolitical tensions, and advancements in AI-enabled analytics and multi-sensor fusion technologies. North America leads the market while Asia-Pacific shows the fastest growth potential.

RTX - Listed as a leading market player in the growing airborne ISR sector, positioned to benefit from projected 6.2% CAGR growth through 2030.

#airborne ISR #intelligence surveillance reconnaissance #military modernization #unmanned aerial systems #AI-enhanced analytics #multi-sensor fusion #counterterrorism #geopolitical tensions #defense technology

Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - SNS Insider

GlobeNewswire Inc. • Sns Insider

Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - SNS Insider

01/09/2026 04:43 AM • The global intraocular lens market is projected to grow from USD 5.97 billion in 2025 to USD 9.85 billion by 2033, driven by rising cataract prevalence, aging populations, and advanced lens technologies. However, high costs of premium lenses and limited accessibility in developing regions remain key challenges. North America leads the market with 38.61% share, while Asia Pacific is expected to witness the fastest growth at 7.03% CAGR.

AAPL - Reduced stake by 15%, selling 42 million shares, but still maintains it as the largest portfolio position
JNJ - Launched TECNIS PureSee™ intraocular lens in India in February 2025, specifically designed for presbyopia correction, indicating active product innovation and market expansion in emerging markets.

#intraocular lens #cataract surgery #premium IOLs #ophthalmology #medical devices #aging population #vision correction

Google Bets On AI To Fix Email Overload With Gemini-Enhanced Gmail— What's New?

Benzinga • Ananya Gairola

Google Bets On AI To Fix Email Overload With Gemini-Enhanced Gmail— What's New?

01/09/2026 03:58 AM • Alphabet's CEO Sundar Pichai announced that Google is integrating its Gemini AI model into Gmail to help users manage email overload. New features include AI Overviews that summarize long email threads and AI Inbox, a personalized briefing section highlighting priority emails and suggested tasks. AI Inbox will initially roll out to Google AI Pro and Ultra subscribers in the U.S.

GOOG - Google is launching significant AI-powered features in Gmail to address user pain points with email overload. The integration of Gemini into Gmail represents a major product upgrade and demonstrates Alphabet's continued innovation in AI applications. The rollout of premium features to paid subscribers also presents potential revenue opportunities through Google AI Pro and Ultra tiers.

#Gemini AI #Gmail #AI Overviews #AI Inbox #email management #artificial intelligence #Sundar Pichai

FORVIA AND SINOPEC CAPITAL PARTNER TO ACCELERATE HYDROGEN GROWTH IN CHINA

GlobeNewswire Inc. • Na

FORVIA AND SINOPEC CAPITAL PARTNER TO ACCELERATE HYDROGEN GROWTH IN CHINA

01/09/2026 02:00 AM • FORVIA announces a strategic partnership with Sinopec Capital, China's leading energy company, through a RMB 300 million (€40 million) minority investment in FORVIA Hydrogen Solutions China. The partnership aims to strengthen FORVIA's position in China's rapidly growing hydrogen market, which produced 36.5 million tons of hydrogen in 2024 and targets 500,000 hydrogen vehicles by 2030. China represents 21% of FORVIA's global sales at approximately €5.9 billion.

FAURY - Strategic partnership with major Chinese energy player strengthens market position in high-growth hydrogen sector; China is a key market representing 21% of global sales; partnership provides access to government contracts and industrial synergies in a government-backed priority sector.

#hydrogen energy #China market expansion #strategic partnership #clean mobility #energy transition #hydrogen fuel cells #capital investment

FORVIA et SINOPEC s'associent pour accélérer la croissance de l'hydrogène en Chine

GlobeNewswire Inc. • Na

FORVIA et SINOPEC s'associent pour accélérer la croissance de l'hydrogène en Chine

01/09/2026 02:00 AM • FORVIA has announced a strategic partnership with Sinopec, China's leading energy and chemistry company, through a 300 million RMB (€40M) capital increase in FORVIA Hydrogen Solutions China. The partnership aims to strengthen FORVIA's position in China's rapidly growing hydrogen market, which produced 36.5 million tonnes in 2024 and is targeting 500,000 hydrogen vehicles by 2030. The collaboration will provide access to key public contracts and industrial synergies.

FAURY - Strategic partnership with major Chinese energy leader Sinopec strengthens market position, provides access to key public contracts, and supports growth in the high-potential Chinese hydrogen market. China represents 21% of FORVIA's global sales (€5.9B), making this partnership strategically significant for future expansion.

#hydrogen #China #strategic partnership #capital investment #clean mobility #energy transition #fuel cell vehicles

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

GlobeNewswire Inc. • Zealand Pharma

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

01/09/2026 02:00 AM • Zealand Pharma has partnered with DCAI to access Gefion, Denmark's flagship AI supercomputer, to accelerate drug discovery and development. The agreement will support Zealand Pharma's Metabolic Frontier 2030 strategy, which aims to deliver five launches, over 10 clinical pipeline programs, and industry-leading cycle times from idea to clinic by 2030. Gefion's infrastructure includes over 1,500 NVIDIA GPUs powered by renewable energy, enabling large-scale protein-peptide simulations and advanced AI modeling for drug discovery.

ZLDPY - The company is gaining access to cutting-edge AI computational infrastructure that directly supports its strategic goals. This partnership enhances drug discovery capabilities, potentially accelerating development timelines and supporting the ambitious Metabolic Frontier 2030 strategy with 10+ clinical programs and faster cycle times.

#AI supercomputer #drug discovery #peptide therapeutics #metabolic health #clinical pipeline #computational power #AI infrastructure

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

Benzinga • Vishaal Sanjay

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

01/09/2026 01:52 AM • Merck & Co. is in advanced talks to acquire cancer drug-maker Revolution Medicines for $28-32 billion, marking potentially the largest biotech M&A deal since Pfizer's $43 billion Seagen acquisition in 2023. Revolution Medicines' stock surged 15.14% overnight on the news. The deal reflects Merck's acquisition strategy amid an industry patent cliff, following recent purchases of Cidara Therapeutics and Verona Pharma.

MRK - Merck is actively pursuing strategic acquisitions to strengthen its cancer drug portfolio and address upcoming patent expirations, particularly for Keytruda in 2028. The deal demonstrates growth strategy and market positioning.

#M&A #biotech acquisition #cancer drugs #patent cliff #pharmaceutical industry #deal valuation

Trends and Investments in Fiberboard Packaging Market 2025-35

GlobeNewswire Inc. • Towards Packaging

Trends and Investments in Fiberboard Packaging Market 2025-35

01/09/2026 12:31 AM • The global fiberboard packaging market is expected to expand at a CAGR of 3.5% from $372.60 billion in 2025 to $525.59 billion by 2035, driven by rising demand for sustainable, lightweight, and cost-effective packaging solutions across food, e-commerce, and consumer goods industries. Asia Pacific dominates the market while North America shows the fastest growth, with key players including Smurfit Westrock, International Paper, and Mondi Group making significant strategic acquisitions and innovations.

SW - Identified as the world's largest sustainable paper-based packaging company formed by 2024 merger; recently launched innovative Bag-in-Box Powergrip solution in September 2025 to replace plastic containers, demonstrating strong product innovation and market leadership.

#fiberboard packaging #sustainable packaging #corrugated cardboard #e-commerce packaging #recycled materials #market growth #Asia Pacific #North America